Cellsway
Liquid biopsy for cancer monitoring through isolation and counting Circulating Tumor Cells (CTCs) from blood.
5 employees · est. 2020 · Ankara, United Kingdom
Exosome Diagnostics, a Bio-Techne brand
ExoDx Prostate is the only exosome-based, non-DRE, simple urine test to assess risk for HGPCa and guide biopsy decision.
103 employees · est. 2008 · Waltham, United States
Exosome Diagnostics, a Bio-Techne brand is the older company (2020 vs 2008); Exosome Diagnostics, a Bio-Techne brand is the larger of the two.
Side-by-Side Comparison
| Metric | Cellsway | Exosome Diagnostics, a Bio-Techne brand |
|---|---|---|
| Founded | ||
| Founded | 2020 | 2008 older |
| Headquarters | ||
| Headquarters | Ankara, United Kingdom | Waltham, United States |
| Employees | ||
| Employees | 5 | 103 larger |
| Industry | ||
| Industry | Biotechnology, Health Care | Biotechnology, Health Care |
| Funding Stage | ||
| Funding Stage | Unknown | Series C |
| Total Funding | ||
| Total Funding | $1.45M | $112.08M |
| Funding Rounds | ||
| Funding Rounds | 5 | 6 |
| Services | ||
| Services | CTC Liquid Biopsy Platform, CTC Enrichment Device, CTC Test Panels | Not tracked yet |
| Target Customers | ||
| Target Customers | Oncologists, Cancer Research Laboratories, Healthcare Institutions, Service Laboratories | Not tracked yet |
| Taxonomy | ||
| Taxonomy | Liquid Biopsy, Circulating Tumor Cells, Cancer Monitoring, Cancer Diagnostics, Microfluidic Technology, Lab-on-a-Chip, Biomedical Engineering, Minimally Invasive Diagnostics, Cancer Research, CTC Isolation, CTC Enumeration, Cancer Management, Deep-Tech Startup | Exosome-based Diagnostics, Liquid Biopsy, Prostate Cancer, Biopsy Decision, Molecular Diagnostics, Minimally Invasive, Nucleic Acid Profiles, Cancer Detection, Urine Test, Blood Test, Cancer Therapies, Non-invasive Testing, Cancer Biomarkers, Precision Medicine |
| Website | ||
| Website | cellsway.com | exosomedx.com |
About Cellsway
Cellsway is a promising deep-tech startup, established in March 2020 in the UK, with a focus on revolutionizing cancer diagnostics and management. The company has successfully translated its expertise from Mikro Biyosistemler Inc. into a commercial product aimed at setting a new gold standard in the...
About Exosome Diagnostics, a Bio-Techne brand
Exosome Diagnostics, Inc., founded in 2008 and headquartered in the United States, is making significant strides in the biotechnology and healthcare industries. The company's slogan, "ExoDx Prostate is the only exosome-based, non-DRE, simple urine test to assess risk for HGPCa and guide biopsy decis...
We will tell you when either one moves
BounceWatch watches Cellsway and Exosome Diagnostics, a Bio-Techne brand for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Cellsway and Exosome Diagnostics, a... — by email.
Frequently Asked Questions
Compare Cellsway with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at Cellsway on 6 Feb 2026, and Exosome Diagnostics, a Bio-Techne brand on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.